Quantification of CYP2B7, CYP4B1, and CYPOR Messenger RNAs in Normal Human Lung and Lung Tumors

Cancer Research

Volumn 54, Issue 4, 1994, Pages 1085-1091

  Czerwinski, Maciej ^a   McLemore, Theodore L ^b   Gelboin, Harry V ^a   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE; XENOBIOTIC AGENT;

ARTICLE; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; FREQUENCY ANALYSIS; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG TUMOR; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TISSUE SPECIFICITY; TUMOR DIAGNOSIS; XENOBIOTIC METABOLISM;

CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; HUMANS; LIVER; LUNG; LUNG NEOPLASMS; NADPH-FERRIHEMOPROTEIN REDUCTASE; RNA, MESSENGER; SMOKING; TUMOR CELLS, CULTURED;

EID: 0028315963     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Guengerich, P.F. Enzymatic oxidation of xenobiotic chemicals. Crit. Rev. Biochem. Mol. Biol., 25: 97-153, 1990.
2. Guengerich, P.F. Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res., 48: 2946-2954, 1988.
3. Wheeler, C.W., and Guenthner, T.M. Cytochrome P-450-dependent metabolism of xenobiotics in human lung. J. Biochem. Toxicol., 3: 163-169, 1991.
4. Nelson, S.D., and Pearson, P.G. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu. Rev. Pharmacol. Toxicol., 30: 169-195, 1990.
5. Nhamburo, P.T., Kimura, S., McBride, O.W., Gelboin, H.V., and Gonzalez, F.J. The human CYP2F subfamily: identification of a cDNA coding for a new cytochrome P450 expressed in lung, cDNA-directed expression and chromosome mapping. Biochemistry, 29: 5491-5499, 1990.
6. Nhamburo, P.T., Gonzalez, F.J., McBride, O. W., Gelboin, H.V., and Kimura, S. Identification of a new P450 expressed in human lung: complete cDNA sequence, cDNA-directed expression and chromosome mapping. Biochemistry, 28: 8060-8068, 1989.
7. Shimada, T., Yun, C.H., Yamazaki, H., Gautier, J.C., Beaune, P.H., and Guengerich, F.P. Characterization of human lung microsomal cytochrome P450 1 Al and its role in the oxidation of chemical carcinogens. Mol. Pharmacol., 41: 856-864, 1992.
8. Yost, G.S. Mechanism of 3-methylindole pneumotoxicity. Chem. Res. Toxicol., 2: 273-279, 1989.
9. McLemore, T.L., Adelberg, S., Liu, M.C., McMahon, N.A., Yu, S.J., Hubbard, W.C., Czerwinski, M., Wood, T.J., Storeng, R., Lubet, R.A., Eggelston, J.C., Boyd, M.R., and Hines, R.A. Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smoke-induced expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J. Natl. Cancer Inst., 82: 1333-1339, 1990.
10. Yamano, S., Nhamburo, P.T., Aoyama, T., Mayer, U.A., Inaba, T., Kalow, W., Gelboin, H.V., McBride, O. W., and Gonzalez, F.J. cDNA cloning and sequence, and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression in human liver. Biochemistry, 28: 7340-7348, 1989.
11. Yamano, S., Aoyama, T., McBride, O.W., Hardwick, J.P., Gelboin, H.V., and Gonzalez, F.J. Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYP OR gene to chromosome 7. Mol. Pharmacol., 35: 83-88, 1989.
12. Guengerich, P.F. Purification and characterization of xenobiotic-metabolizing enzymes from lung tissue. Pharmacol. Ther., 45: 299-307, 1990.
13. Friedberg, T., Grassow, M.A., and Oesh, F. Selective detection of RNA forms encoding the major phenobarbital inducible cytochromes P450 and other members of the P450IIB family by RNase protection assay. Archives of Biochemistry and Biophysics, 279: 167-174, 1984.
14. Shephard, E.A., Palmer, C.N.A., Segall, H.J., and Philips, I.R. Quantification of cytochrome P450 reductase gene expression in human tissues. Arch. Biochem. Bio-phys., 294: 168-172, 1992.
15. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J., and Rutter, W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
16. Chomczynski, P., and Sacchi, N. Single-step RNA isolation by acid guanidinium thiocyanate-phenol-chlorophorm extraction. Anal. Biochem., 762: 156-159, 1987.
17. Ausbel, F.M., Bret, R., Kington, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Sthrul, K. (eds.). Current Protocols in Molecular Biology, Chap. 4.7. New York: John Wiley and Sons, 1989.
18. Transcription In Vitro Systems. Technical Manual. Promega Corporation, Madison, WI, 1990.
19. Ponte, P., Gunning, P., Blau, H., and Kedes, L. Human actin genes are single copy for a-skeletal and a-cardiac actin but multicopy for β- and y-cytoskeletal genes: 3' untranslated regions are isotype specific but are conserved in evolution. Mol. Cell Biol., 3: 1783-1791, 1983.
20. Shoemaker, R.H., Monks, A., Alley, M.C., Scudiero, D.C., Fine, D.L., McLemore, T.L., Abbott, B.J., Paull, K.D., Mayo, J.G., and Boyd, M.R. Development of human tumor cell lines panel for use in disease-oriented drug screening. In: Prediction of Response to Cancer Therapy, pp. 265-286. New York: Allan R. Liss, 1987.
21. Shephard, E.A., Philips, I.R., Bayney, R.M., Pike, S.F., and Rabin, B.R. Quantification of NADPH: cytochrome P-450 reductase in liver microsomes by a specific radioimmunoassay technique. Biochem. J., 21: 333-340, 1983.
22. Richards, R.J., Oreffo, V.I.C., and Lewis, R.W. Clara cell cultures from the mouse and their reaction to bronchiolar toxins. Environ. Health Perspect., 85: 119-127, 1990.
23. Volm, M., Mattern, J., Efferth, T.T., and Pommerenke, E.W. Expression of several resistance mechanisms in untreated human kidney and lung carcinomas. Anticancer Res., 12: 1063-1068, 1992.
24. Gazdar, A.F. Cell biology and molecular biology of small cell and non-small cell lung cancer. Curr. Opin. Oncol., 2: 321-327, 1990.
25. Buege, J.A., and Aust, S.D. Microsomal lipid peroxidation. In: S. Fleischer and L. Packer, (eds.), Methods in Enzymology Vol. 52, pp. 302-310. New York: Academic Press, 1978.
26. Guengerich, F.P., and Strickland, T.W. Metabolism of vinyl chloride: destruction of the heme of highly purified liver microsomal cytochrome P-450 by a metabolite. Mol. Pharmacol., 13: 993-1004, 1977.
27. Re, F.C., Maneti, G., Borrello, M.G., Colombo, M.P., Fisher, J.H., Pierotti, M.A., Delia Porta, G., and Dragani, T.A. Multiple molecular alterations in mouse lung tumors. Mol. Carcinog., 5: 155-160, 1992.
28. Ayesh, R., Idle, J.R., Crothers, M.R., and Hetzel, M.R. Metabolic oxidation phenotypes as markers of lung cancer susceptibility. Nature (Lond.), 312: 169-170, 1984.